500,000 patients’ data for sale online after UK Biobank breach
Last week, data from 500,000 participants of UK Biobank’s database were made available for sale online following a breach, the…
All articles by Ross Law
Ross Law
Ross Henry Law is a reporter for Medical Device Network. His key interest areas in healthcare include regulation, mental health, neurology, oncology, and Alzheimer's disease. Ross also has extensive prior experience in covering the captive insurance, retail, and technology sectors.
-
-
Boehringer Ingelheim launches AI centre in London
Boehringer Ingelheim has launched a new artificial intelligence (AI) and machine learning (ML) centre in London, representing the company’s latest…
-
Magazine: Digital twins become the new battleground for CDMOs
Contract Development and Manufacturing Organisations’ (CDMOs) expansion into more complex biopharmaceuticals, gene therapy and advanced product sectors is prompting a…
-
Advancing single-cell transcriptomics into the mainstream of biomedical research
Kelly Parliament, staff application scientist at Beckman Coulter Life Sciences, discusses how automation is improving the efficiency of single-cell transcriptomic…
-
Tariffs, uncertainty and disruption: how drug makers and distributors can build operational supply chain resilience
Ryan Rotar, vice president of healthcare market strategy at Tecsys, outlines how supply chain resilience can be maintained in the…
-
Magazine: Smart and connected packaging
With the recent conclusion of PharmaPack 2026, this month’s magazine is focused on the key messaging that emanated from the event. With…
-
Internet of Medical Things beats AI as top ranked growth driver among life science CEOs
A new report has revealed that 83% of life sciences CEOs view Internet of Medical Things (IoMT) devices as the…
-
The new safety mandate driving AI-ready pharmacovigilance
Regulatory expectations in the drug safety industry have evolved faster in the past five years than in the previous two…
-
When trillion‑member libraries meet physics: what diversity really means
Dr Karsten Eastman, CEO, Sethera Therapeutics, highlights the challenges around ‘true’ diversification in DNA libraries. In drug discovery, big numbers…
-
Podcast: JPM26’s dealmaking falls short of expectations
This year's J.P. Morgan Healthcare Conference wrapped up without the usual high level of M&A we've grown accustomed to. Boston…